CH625526

Cephalosporin antibiotics in which the 7 beta -acylamido group has the structure (WHERE R is phenyl, thienyl or furyl; Ra and Rb are each selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl, aminocarbonyl, N-substituted am...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GORDON IAN GREGORY, MICHAEL WALTER FOXTON, DAVID MALCOLM ROGERS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GORDON IAN GREGORY
MICHAEL WALTER FOXTON
DAVID MALCOLM ROGERS
description Cephalosporin antibiotics in which the 7 beta -acylamido group has the structure (WHERE R is phenyl, thienyl or furyl; Ra and Rb are each selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl, aminocarbonyl, N-substituted aminocarbonyl and cyano, or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkylidene or cycloalkenylidene group; Rc is hydrogen or C1-4 alkyl; and m and n are each 0 or 1 such that the sum of m and n is 0 or 1) exhibit broad spectrum antibiotic activity characterized by particularly high activity against gram negative microorganisms, including those which produce beta -lactamases. The compounds, which are syn isomers or exist as mixtures of syn and anti isomers containing at least 90% of the syn isomer, have particularly good activity against Proteus organisms including indole positive strains and, especially when both Ra and Rb are other than hydrogen, against Pseudomonas organisms.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CH625526A5</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CH625526A5</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CH625526A53</originalsourceid><addsrcrecordid>eNrjZOBw9jAzMjU1MuNhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfEw5Y6mxoRVAACKDRni</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>CH625526</title><source>esp@cenet</source><creator>GORDON IAN GREGORY ; MICHAEL WALTER FOXTON ; DAVID MALCOLM ROGERS</creator><creatorcontrib>GORDON IAN GREGORY ; MICHAEL WALTER FOXTON ; DAVID MALCOLM ROGERS</creatorcontrib><description>Cephalosporin antibiotics in which the 7 beta -acylamido group has the structure (WHERE R is phenyl, thienyl or furyl; Ra and Rb are each selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl, aminocarbonyl, N-substituted aminocarbonyl and cyano, or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkylidene or cycloalkenylidene group; Rc is hydrogen or C1-4 alkyl; and m and n are each 0 or 1 such that the sum of m and n is 0 or 1) exhibit broad spectrum antibiotic activity characterized by particularly high activity against gram negative microorganisms, including those which produce beta -lactamases. The compounds, which are syn isomers or exist as mixtures of syn and anti isomers containing at least 90% of the syn isomer, have particularly good activity against Proteus organisms including indole positive strains and, especially when both Ra and Rb are other than hydrogen, against Pseudomonas organisms.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1981</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19810930&amp;DB=EPODOC&amp;CC=CH&amp;NR=625526A5$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19810930&amp;DB=EPODOC&amp;CC=CH&amp;NR=625526A5$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GORDON IAN GREGORY</creatorcontrib><creatorcontrib>MICHAEL WALTER FOXTON</creatorcontrib><creatorcontrib>DAVID MALCOLM ROGERS</creatorcontrib><title>CH625526</title><description>Cephalosporin antibiotics in which the 7 beta -acylamido group has the structure (WHERE R is phenyl, thienyl or furyl; Ra and Rb are each selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl, aminocarbonyl, N-substituted aminocarbonyl and cyano, or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkylidene or cycloalkenylidene group; Rc is hydrogen or C1-4 alkyl; and m and n are each 0 or 1 such that the sum of m and n is 0 or 1) exhibit broad spectrum antibiotic activity characterized by particularly high activity against gram negative microorganisms, including those which produce beta -lactamases. The compounds, which are syn isomers or exist as mixtures of syn and anti isomers containing at least 90% of the syn isomer, have particularly good activity against Proteus organisms including indole positive strains and, especially when both Ra and Rb are other than hydrogen, against Pseudomonas organisms.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1981</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZOBw9jAzMjU1MuNhYE1LzClO5YXS3Azybq4hzh66qQX58anFBYnJqXmpJfEw5Y6mxoRVAACKDRni</recordid><startdate>19810930</startdate><enddate>19810930</enddate><creator>GORDON IAN GREGORY</creator><creator>MICHAEL WALTER FOXTON</creator><creator>DAVID MALCOLM ROGERS</creator><scope>EVB</scope></search><sort><creationdate>19810930</creationdate><title>CH625526</title><author>GORDON IAN GREGORY ; MICHAEL WALTER FOXTON ; DAVID MALCOLM ROGERS</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CH625526A53</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1981</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GORDON IAN GREGORY</creatorcontrib><creatorcontrib>MICHAEL WALTER FOXTON</creatorcontrib><creatorcontrib>DAVID MALCOLM ROGERS</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GORDON IAN GREGORY</au><au>MICHAEL WALTER FOXTON</au><au>DAVID MALCOLM ROGERS</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>CH625526</title><date>1981-09-30</date><risdate>1981</risdate><abstract>Cephalosporin antibiotics in which the 7 beta -acylamido group has the structure (WHERE R is phenyl, thienyl or furyl; Ra and Rb are each selected from hydrogen, C1-4 alkyl, C2-4 alkenyl, C3-7 cycloalkyl, phenyl, naphthyl, thienyl, furyl, carboxy, C2-5 alkoxycarbonyl, aminocarbonyl, N-substituted aminocarbonyl and cyano, or Ra and Rb together with the carbon atom to which they are attached form a C3-7 cycloalkylidene or cycloalkenylidene group; Rc is hydrogen or C1-4 alkyl; and m and n are each 0 or 1 such that the sum of m and n is 0 or 1) exhibit broad spectrum antibiotic activity characterized by particularly high activity against gram negative microorganisms, including those which produce beta -lactamases. The compounds, which are syn isomers or exist as mixtures of syn and anti isomers containing at least 90% of the syn isomer, have particularly good activity against Proteus organisms including indole positive strains and, especially when both Ra and Rb are other than hydrogen, against Pseudomonas organisms.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_CH625526A5
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title CH625526
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A43%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GORDON%20IAN%20GREGORY&rft.date=1981-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECH625526A5%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true